|Date||Millions of Won||Variation|
|2014||3 161 712.80||4.39|
|2013||3 028 769.50||9.55|
|2012||2 764 616.80||4.23|
|2011||2 652 316.20||4.63|
|2010||2 535 003.20||35.26|
|2009||1 874 151.50||42.74|
|2008||1 312 995.00||-2.91|
|2007||1 352 410.40||-15.92|
|2006||1 608 454.40||15.12|
|2005||1 397 212.20||-5.51|
- Financing Scheme
- All Financing Schemes
- Compulsory Contributory Health Insurance Schemes
- Cost-sharing With Third-party Payers
- Government Schemes
- Government Schemes And Compulsory Contributory Health Care Financing Schemes
- Household Out of Pocket Payment
- Out of Pocket Excluding Cost-sharing
- Private Expenditure on Health
- Voluntary Health Care Payment Schemes
- Voluntary Health Insurance Schemes
- Type of Provider
Spending On Medicines in other Countries
Main Pharmaceutical Indicators
Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.
Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.
Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.
Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.
Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.
Drug sales in DDD (defined daily dosis)
Sales of generic drugs. These are defined as an identical - or bioequivalent - to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Usually expressed in value (million or billion of national currency). Based on: U.S. Food & Drug Administration.
Percentage of total pharmaceutical sales that can be attributed to generic pharmaceutical products. These are defined as an identical - or bioequivalent - to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Based on: U.S. Food & Drug Administration.
Sales of contraceptives in defined daily dosis (DDD). The latter consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.